Highly active hyperimmune sera to H2N2 viruses devoid of nonspecific inhibitors
Ismaĭlova, I.M.
Voprosy Virusologii 28(6): 744-747
1983
ISSN/ISBN: 0507-4088 PMID: 6367221 Document Number: 197097
Document emailed within 1 workday
Related Documents
Zakstel'skaia, L.I.; Shenderovich, S.F. 1979: Method of removing nonspecific hemagglutination inhibitors from diagnostic and postinfection sera Voprosy Virusologii 5: 560-561Scherer, W.F.; Reeves, W.C.; Hardy, J.L.; Miura, T. 1972: Inhibitors of Western and Venezuelan equine encephalitis viruses in cattle sera from Hawaii American Journal of Tropical Medicine and Hygiene 21(2): 189-193
Klimova, K.N.; Mineeva, N.V. 1986: The role of factors influencing the hemagglutination reaction in the preparation of highly active typing anti-erythrocyte sera and detection of alloantibodies Gematologiia i Transfuziologiia 31(12): 40-46
Ghyka, G.; Samuel, I.; Portocală, R. 1978: Immunoelectrophoretic study of Sendae virus envelope antigens with hyperimmune sera prepared in different laboratory animals Virologie 29(1): 23-28
Levina, E.N.; Frolov, V.M.; Shuster, M.A.; Savitskaia, K.I.; Iurina, T.M. 1981: Characteristics of the immunity and nonspecific reactivity indices in chronic suppurative mesotympanitis in the treatment with hyperimmune plasmas Vestnik Otorinolaringologii 5: 18-20
Sulaiman, M.M.; Shettima, J.; Ummate, I.; Arogundade, F.A.; Yusuph, H.; Nwankwo, E.; Sanusi, A.A.; Akinsola, A. 2022: Comparative Evaluation of Prevalence, Risk Factors, and Pathologic Features of Kidney Disease in Highly Active Antiretroviral Therapy-Naive and Highly Active Antiretroviral Therapy-Experienced Patients at a Tertiary Health Facility in Maiduguri, Northeastern Nigeria Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 33(1): 72-79
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Li, B.R.; Tong, S.Q.; Zhang, X.H.; Lu, J.; Gu, Q.L.; Lu, D.Y. 1994: A new experimental and clinical approach of combining usage of highly active tumor-infiltrating lymphocytes and highly sensitive antitumor drugs for the advanced malignant tumor Chinese Medical Journal 107(11): 803-807
Chang, G.; Ruggeri, R.B.; Harwood, H.James. 2002: Microsomal triglyceride transfer protein (MTP) inhibitors: discovery of clinically active inhibitors using high-throughput screening and parallel synthesis paradigms Current Opinion in Drug Discovery and Development 5(4): 562-570
Bonaros, N.E.; Kocher, A.; Dunkler, D.; Grimm, M.; Zuckermann, A.; Ankersmit, J.; Ehrlich, M.; Wolner, E.; Laufer, Günther. 2004: Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients Transplantation 77(6): 890-897
Darwsh, M.A.; Imam, Z.E.; Amer, T. 1974: Antibodies to Dhori and Wanowrie viruses in Egyptian sera Journal of the Egyptian Public Health Association 49(6): 362-368
Ketiladze, E.S.; Ivanova, L.A.; Eliseeva, I.I.; Demidova, S.A.; Poliakova, T.G. 1986: Significance of various respiratory viruses in the development of chronic nonspecific bronchopulmonary processes Voprosy Virusologii 31(3): 310-314
Slepushkin, A.N.; Ritova, V.V.; Fedorova, G.I.; Feklisova, L.V.; Obrosova-Serova, N.P. 1983: Humoral immunity to influenza a and B viruses in the blood sera of children younger than 14 in 1981 Voprosy Virusologii 28(5): 564-567
Phadke, A.R.; Niphadkar, K.B.; Deodhare, S.G. 1971: Antibodies against Coxsackie group B viruses using HAi tests in the human sera collected from poona Journal of Postgraduate Medicine 17(3): 103-107
Obuchi, M.; Tashiro, M. 2010: Current situation in human infections with highly pathogenic avian influenza viruses Nihon Rinsho. Japanese Journal of Clinical Medicine 68(9): 1729-1735
Bopegamage, S.A.; Petrovicová, A. 1998: Tumour necrosis factor alfa and glucose levels in sera of mice infected with coxsackie B4 and A7 viruses Acta Virologica 42(6): 409-411
al-Muzairai, I.A.; MacLeod, A.M.; Cochrane, S.; Jones, M.C.; Propper, D.; Catto, G.R. 1989: Anti-idiotypic activity in cytotoxic sera from highly sensitised patients (HSP) given cyclosporin A and blood transfusion from a specific donor (ST) Transplantation Proceedings 21(1 Pt 1): 748-749
Goldsmith, J.C. 1993: Diagnosis of factor VIIi versus nonspecific inhibitors Seminars in Hematology 30(2 Suppl 1: 3-6
Gates, A.E.; Kaplan, L.D. 2002: AIDS malignancies in the era of highly active antiretroviral therapy Oncology 16(5): 657-665; Discussion 665: 668-670